Abstract

Envenomings by snakebites and scorpion stings impose a high burden worldwide and result in considerable social and economic impact [1]. It is estimated that snakebite rates are as high as over 1.8 million cases per year, with associated deaths reaching more than 90,000 cases annually [2]. However, snakebites are a neglected condition with no associated WHO programmes for control and prevention. The countries most affected by snakebites are located in the intertropical zone in areas with high rates of field use for agriculture where the main affected populations are adult men working in agricultural activities [1]. Approximately two billion people are living in areas at risk for scorpion stings, with over one million accidents occurring annually worldwide [3]. However, the true burden of snakebites and scorpion stings is probably higher and difficult to estimate since only a few countries have a reliable system for epidemiological surveillance of these events. In Brazil, the Ministry of Health implemented the National Program for Snakebites Control in 1986, extended to other poisonous animals in 1988. Since then, antivenom (AV) production has been standardized and all the AV production from the three national laboratories (Instituto Butantan, Fundacao Ezequiel Dias, and Instituto Vital Brazil) was acquired by the Ministry of Health for distribution free of charge to patients. Five types of snake AVs are currently available: Bothrops AV (main one), Crotalus AV, Bothrops-Crotalus AV, Bothrops-Lachesis AV, and Micrurus AV. For scorpion stings, there are two types of AVs available in Brazil: Tityus scorpion AV and a polyvalent AV against Loxosceles and Phoneutria spiders and the Tityus scorpion. Table 1 summarizes information on snake and scorpion AVs produced in Brazil. Table 1 Venom pools used for snake and scorpion AVs production in Brazil. In 2013, 27,181 and 78,091 cases of snakebites and scorpion stings were reported by the Brazilian Ministry of Health, respectively [4]. The highest incidence was in the North region (52.6 cases/100,000 inhabitants) followed by the Midwest (16.4/100,000). These values, expected to be higher in remote areas of the Brazilian Amazon [5], may be underestimated due to considerable underreporting. Fig 1 presents the spatial distribution of snakebites and scorpion stings in the Brazilian Amazon. Fig 1 Spatial distribution of snakebites and scorpion stings in the Brazilian Amazon in 2013.

Highlights

  • Despite important efforts carried out during the past decades in Brazil to understand and control the problem of snakebite and scorpion sting envenomings, important gaps remain for the fulfillment of these goals, in the Amazon region

  • A workshop was held in Manaus, Amazonas, in 2013 with representatives of Health Departments of Amazonian states, AV producers, universities, reference hospitals, and the Ministry of Health to identify research bottlenecks

  • Bothrops atrox (A) is implicated in most of the human snakebites registered in the Brazilian Amazon region (80%–90%), followed by Lachesis muta (E). doi:10.1371/journal.pntd.0003701.g002

Read more

Summary

POLICY PLATFORM

Snakebites and Scorpion Stings in the Brazilian Amazon: Identifying Research Priorities for a Largely Neglected Problem. Fan Hui Wen, Wuelton Marcelo Monteiro2,3*, Ana Maria Moura da Silva, Denise V. Maria Cristina dos Santos, Jacqueline Sachett, Luiz Carlos L.

OPEN ACCESS
Snake AVs Bothrops AV
The Brazilian Amazon
Research Gaps
Burden on vulnerable populations
Venom research and revision of the AV spectrum
Priorities in clinical research
Adverse reactions and pharmacovigilance
Professional training
Findings
Fauna surveys and capture of animals for venom production
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call